1. Home
  2. NVAX vs ZD Comparison

NVAX vs ZD Comparison

Compare NVAX & ZD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVAX
  • ZD
  • Stock Information
  • Founded
  • NVAX 1987
  • ZD 1995
  • Country
  • NVAX United States
  • ZD United States
  • Employees
  • NVAX N/A
  • ZD N/A
  • Industry
  • NVAX Biotechnology: Biological Products (No Diagnostic Substances)
  • ZD Advertising
  • Sector
  • NVAX Health Care
  • ZD Consumer Discretionary
  • Exchange
  • NVAX Nasdaq
  • ZD Nasdaq
  • Market Cap
  • NVAX 1.3B
  • ZD 1.3B
  • IPO Year
  • NVAX 1995
  • ZD 1999
  • Fundamental
  • Price
  • NVAX $6.84
  • ZD $32.68
  • Analyst Decision
  • NVAX Buy
  • ZD Hold
  • Analyst Count
  • NVAX 5
  • ZD 6
  • Target Price
  • NVAX $16.60
  • ZD $49.67
  • AVG Volume (30 Days)
  • NVAX 4.9M
  • ZD 603.4K
  • Earning Date
  • NVAX 08-07-2025
  • ZD 08-06-2025
  • Dividend Yield
  • NVAX N/A
  • ZD N/A
  • EPS Growth
  • NVAX N/A
  • ZD 36.58
  • EPS
  • NVAX 2.97
  • ZD 1.76
  • Revenue
  • NVAX $1,254,962,000.00
  • ZD $1,415,839,000.00
  • Revenue This Year
  • NVAX $56.85
  • ZD $7.37
  • Revenue Next Year
  • NVAX N/A
  • ZD $3.65
  • P/E Ratio
  • NVAX $2.30
  • ZD $19.20
  • Revenue Growth
  • NVAX 25.92
  • ZD 3.24
  • 52 Week Low
  • NVAX $5.01
  • ZD $29.15
  • 52 Week High
  • NVAX $17.81
  • ZD $60.62
  • Technical
  • Relative Strength Index (RSI)
  • NVAX 51.12
  • ZD 52.60
  • Support Level
  • NVAX $6.54
  • ZD $32.13
  • Resistance Level
  • NVAX $7.20
  • ZD $34.14
  • Average True Range (ATR)
  • NVAX 0.28
  • ZD 1.40
  • MACD
  • NVAX 0.06
  • ZD 0.23
  • Stochastic Oscillator
  • NVAX 66.36
  • ZD 65.57

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from the United States.

About ZD Ziff Davis Inc.

Ziff Davis Inc is a focused digital media and internet company whose portfolio includes brands in technology, entertainment, shopping, health, cybersecurity, and martech. It has two reportable segments: Digital Media and Cybersecurity and Martech. The company's brands include Mashable, Ookla, Offers.com, IGN, and VPN among others. The majority of revenue is generated from Digital Media.

Share on Social Networks: